Brief: Landos Biopharma Reports Q2 Results

Landos Biopharma

29/07/2021 13:18

July 29 (Reuters) - Landos Biopharma Inc  LABP.O :
    * LANDOS BIOPHARMA REPORTS SECOND QUARTER 2021 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATES
    * LANDOS BIOPHARMA - ENDED Q2 2021 WITH ALL PROGRAMS ON
TRACK AND
$115 MILLION IN CASH AND OPERATING RUNWAY EXTENDING UNTIL END OF
2023
    * LANDOS BIOPHARMA - NET GAIN WAS $4.1 MILLION FOR THREE
MONTHS
ENDED JUNE 30, 2021 COMPARED TO A NET LOSS OF $4.8 MILLION IN
THREE MONTHS ENDED JUNE 30, 2020

Source text for Eikon:  ID:nGNX2KBQyt 
Further company coverage:  LABP.O 

 ((Reuters.Briefs@thomsonreuters.com;))